<DOC>
	<DOCNO>NCT01709929</DOCNO>
	<brief_summary>This trial conduct North America . The aim trial evaluate safety insulin detemir treatment diabetes .</brief_summary>
	<brief_title>Safety Insulin Detemir Treatment Insulin Dependent Type 1 Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Diagnosed type 1 type 2 diabetes Using basal/bolus insulin regimen Subjects unlikely comply protocol , e.g. , uncooperative attitude , inability return final visit Subjects previously enrol study Subjects hypersensitivity insulin detemir excipients</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>